查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
电子处方解决方案市场 - 全球市场规模、份额、趋势分析、机会和预测报告，2019-2029
市场调查报告书
商品编码
1310406

电子处方解决方案市场 - 全球市场规模、份额、趋势分析、机会和预测报告，2019-2029

E-Prescribing Solutions Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product ; By Delivery Mode ; By Usage Method ; By Substances ; By Specialties ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2029 年，全球电子处方解决方案市场将增长五倍以上，达到 138 亿美元

由于越来越注重减少欺诈和滥用受控药物、疾病患病率上升以及减少医疗差错，全球电子处方解决方案市场正在蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近估计，2022 年全球电子处方解决方案市场规模为 27.4 亿美元。 BlueWeave预测，2023年至2029年的预测期内，全球电子处方解决方案市场规模将以26.04%的年复合成长率大幅增长，到2029年将达到137.9亿美元。全球电子处方解决方案市场的主要增长促进因素是医疗保健 IT 解决方案的日益普及、减少用药错误和提高患者安全的需求以及促进电子处方系统采用的政府政策。专注于数字化和医疗保健自动化。电子处方解决方案通过为医疗保健专业人员提供准确和最新的药物信息（包括推荐剂量、过敏和潜在的药物相互作用），对于减少用药错误和提高患者安全至关重要。随着患者安全成为医疗保健领域的首要任务，对电子处方解决方案的需求持续增长。此外，糖尿病、心血管疾病和呼吸系统疾病等慢性病的全球患病率不断上升，进一步需要使用电子处方解决方案。这些解决方案有效管理慢性病患者的药物治疗，减少错误并确保及时开药。因此，慢性病负担的增加正在推动全球电子处方解决方案市场的扩张。然而，高部署成本、安全性和工作流程问题预计将在预测期内抑制整个市场的增长。

该报告的详细分析提供了有关全球电子处方解决方案市场的增长潜力、未来趋势和统计数据的信息。我们还关注推动市场总规模预测的因素。该报告承诺提供全球电子处方解决方案市场的最新技术发展以及行业见解，帮助决策者做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争力。

目录

第1章研究框架

第2章执行摘要

第3章全球电子处方解决方案市场洞察

  • 行业价值链分析
  • DROC分析
    • 增长促进因素
      • 残疾患病率上升
      • 人们对减少医疗差错越来越感兴趣
      • 专注于减少欺诈和管製药物滥用
    • 抑制因素
      • 引进成本高
      • 安全和工作流程问题
    • 机会
      • 由于 COVID-19，集成 Telepath 解决方案的采用率有所提高
      • 政府加大对医疗基础设施的投资
    • 任务
      • 消费者缺乏科技意识
  • 技术进步/最新发展
  • 监管框架
  • 波特五力分析

第4章全球电子处方解决方案市场概述

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 副产品
      • 解决方案
      • 综合解决方案
      • 独立解决方案
      • 服务
      • 支持
      • 执行
      • 训练
      • 通讯网络
    • 按交货方式
      • 基于网络/云
      • 本地
    • 使用方法
      • 手持式
      • 基于计算机的设备
    • 按物质
      • 管制物质
      • 不受控制的物质
    • 按专业
      • 肿瘤学
      • 运动药物
      • 神经病学
      • 心脏病学
      • 其他的
    • 按最终用户
      • 医院
      • 主治医师
      • 药店
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美电子处方解决方案市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 副产品
    • 按交货方式
    • 使用方法
    • 按物质
    • 按专业
    • 按最终用户
    • 按国家/地区
      • 我们
      • 加拿大

第6章欧洲电子处方解决方案市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 副产品
    • 按交货方式
    • 使用方法
    • 按物质
    • 按专业
    • 按最终用户
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第7章亚太电子处方解决方案市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 副产品
    • 按交货方式
    • 使用方法
    • 按物质
    • 按专业
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他地区

第8章拉丁美洲电子处方解决方案市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 副产品
    • 按交货方式
    • 使用方法
    • 按物质
    • 按专业
    • 按最终用户
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东和非洲电子处方解决方案市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 副产品
    • 按交货方式
    • 使用方法
    • 按物质
    • 按专业
    • 按最终用户
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争格局

  • 主要公司及其产品列表
  • 2022年全球电子处方解决方案企业市场份额分析
  • 通过运行参数进行竞争基准测试
  • 主要战略发展（合併、收购、合作伙伴关係等）

第11章COVID-19 对全球电子处方解决方案市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争、联繫地址、战略展望、SWOT分析）

  • Medical information technology, Inc.
  • Eclinicalworks
  • Athenahealth
  • Epic Systems Corporation
  • Change healthcare
  • Surescripts
  • Practice Fusion
  • Drfirst
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • NextGen Healthcare, Inc.
  • eMDs, Inc.
  • Greenway Health, LLC
  • Stratice Healthcare
  • Computer Programs and Systems Inc.
  • Other Prominent Players

第13章关键战略建议

第14章调查方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和数据三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者的地区分布
  • 假设和限制
简介目录
Product Code: BWC23562

Global E-Prescribing Solutions Market Size Zooming More Than 5X to Touch USD 13.8 Billion by 2029.

Global e-prescribing solutions market is flourishing because of an increasing focus on the reduction of fraud and abuse of controlled substances and rising prevalence of disorders, increasing focus on reducing medical errors.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global e-prescribing solutions market size at USD 2.74 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global e-prescribing solutions market size to grow at a significant CAGR of 26.04% reaching a value of USD 13.79 billion by 2029. Major growth drivers for the global e-prescribing solutions market include an increasing adoption of healthcare IT solutions, the need to minimize medication errors and improve patient safety, government initiatives promoting the adoption of e-prescribing systems, and the growing emphasis on digitization and healthcare automation. E-prescribing solutions have a pivotal role in reducing medication errors and enhancing patient safety by equipping healthcare professionals with accurate and up-to-date information on medications, including dosage recommendations, allergies, and potential drug interactions. As healthcare prioritizes patient safety, the demand for e-prescribing solutions continues to grow. Also, the rising prevalence of chronic diseases like diabetes, cardiovascular diseases, and respiratory conditions on a global scale further necessitates the use of e-prescribing solutions. These solutions effectively manage medication for patients with chronic conditions, ensuring timely prescriptions while reducing errors. Consequently, the increasing burden of chronic diseases acts as a driving force behind the expanding global e-prescribing solutions market. However, high cost of deployment and concern regarding security and workflow are anticipated to restrain the overall market growth during the forecast period.

Global E-Prescribing Solutions Market - Overview:

The global e-prescribing solutions market refers to the market encompassing electronic prescription systems used in the healthcare industry. E-prescribing, or electronic prescribing, involves the computer-based generation, transmission, and management of medical prescriptions, replacing traditional paper-based methods. The e-prescribing solutions market includes software platforms and solutions that enable healthcare professionals to electronically create, transmit, and process prescriptions, as well as access patient medication history, drug interaction alerts, and formulary information. The global e-prescribing solutions market is driven by the need to enhance patient safety, minimize medication errors, improve healthcare efficiency, and comply with government regulations promoting digital healthcare initiatives.

Impact of COVID-19 on Global E-Prescribing Solutions Market:

COVID-19 pandemic had a positive impact on the global e-prescribing solutions market. With the focus on reducing physical contact and ensuring patient safety, there has been a heightened demand for contactless healthcare solutions. E-prescribing systems have played a crucial role in enabling remote prescribing, minimizing the need for in-person visits to healthcare facilities. The pandemic has accelerated the adoption of e-prescribing solutions as healthcare providers strive to streamline workflows, reduce transmission risks, and ensure continuity of care. Moreover, the transition towards telemedicine and virtual consultations has underscored the significance of e-prescribing, consequently fueling market expansion both during and after the COVID-19 pandemic.

Global E-Prescribing Solutions Market - By End User:

On basis of the End User, the global e-prescribing solutions market is segmented into Hospital, Office-based Physicians, and Pharmacy segments. The office-based physicians segment holds the highest share in the global e-prescribing solutions market by end user. These include the widespread adoption of e-prescribing systems in outpatient settings, the convenience and efficiency it offers to office-based physicians in managing prescriptions, and the ability to seamlessly integrate e-prescribing with electronic health records for streamlined patient care. Meanwhile, the hospital segment dominates the market in second place. Hospitals are large healthcare facilities that handle a significant volume of patient visits and medication prescriptions. Implementing e-prescribing systems in hospitals helps improve efficiency, reduce medication errors, and enhance patient safety. Additionally, hospitals often have more complex medication management needs, including controlled substances and specialized treatments, which can be effectively managed through e-prescribing solutions. The integration of e-prescribing systems with other hospital systems, such as electronic health records and pharmacy systems, further enhances workflow and coordination, contributing to the segment's significant market share.

Competitive Landscape:

Major players operating in the Global E-Prescribing Solutions Market include: Medical information technology, Inc., Eclinicalworks, Athenahealth, Epic Systems Corporation, Change healthcare, Surescripts, Practice Fusion, Drfirst, Allscripts Healthcare Solutions, Inc., Cerner Corporation, NextGen Healthcare, Inc., eMDs, Inc., Greenway Health, LLC, Stratice Healthcare, and Computer Programs and Systems Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global E-Prescribing Solutions Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global E-Prescribing Solutions Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global E-Prescribing Solutions Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Rising prevalence of disorders
      • 3.2.1.2. Increasing focus on reducing medical errors
      • 3.2.1.3. Rise in focus on the reduction of fraud and abuse of controlled substances
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of deployment
      • 3.2.2.2. Concern regarding security and workflow
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing adoption of integrated telepath solution due to COVID-19
      • 3.2.3.2. Increase in government investments on healthcare infrastructure
    • 3.2.4. Challenges
      • 3.2.4.1. Lack of technological awareness among consumers
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global E-Prescribing Solutions Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Solutions
      • 4.2.1.1.1. Integrated Solutions
      • 4.2.1.1.2. Standalone Solutions
      • 4.2.1.2. Services
      • 4.2.1.2.1. Support
      • 4.2.1.2.2. Implementation
      • 4.2.1.2.3. Training
      • 4.2.1.2.4. Network
    • 4.2.2. By Delivery Mode
      • 4.2.2.1. Web/Cloud-Based
      • 4.2.2.2. On-premises
    • 4.2.3. By Usage Method
      • 4.2.3.1. Handheld
      • 4.2.3.2. Computer-based Devices
    • 4.2.4. By Substances
      • 4.2.4.1. Controlled Substances
      • 4.2.4.2. Non-controlled Substances
    • 4.2.5. By Specialties
      • 4.2.5.1. Oncology
      • 4.2.5.2. Sports Medicine
      • 4.2.5.3. Neurology
      • 4.2.5.4. Cardiology
      • 4.2.5.5. Others
    • 4.2.6. By End User
      • 4.2.6.1. Hospital
      • 4.2.6.2. Office-based Physicians
      • 4.2.6.3. Pharmacy
    • 4.2.7. By Region
      • 4.2.7.1. North America
      • 4.2.7.2. Europe
      • 4.2.7.3. Asia Pacific (APAC)
      • 4.2.7.4. Latin America (LATAM)
      • 4.2.7.5. Middle East and Africa (MEA)

5. North America E-Prescribing Solutions Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By Delivery Mode
    • 5.2.3. By Usage Method
    • 5.2.4. By Substances
    • 5.2.5. By Specialties
    • 5.2.6. By End User
    • 5.2.7. By Country
      • 5.2.7.1. United States
      • 5.2.7.1.1. By Product
      • 5.2.7.1.2. By Delivery Mode
      • 5.2.7.1.3. By Usage Method
      • 5.2.7.1.4. By Substances
      • 5.2.7.1.5. By Specialties
      • 5.2.7.1.6. By End User
      • 5.2.7.2. Canada
      • 5.2.7.2.1. By Product
      • 5.2.7.2.2. By Delivery Mode
      • 5.2.7.2.3. By Usage Method
      • 5.2.7.2.4. By Substances
      • 5.2.7.2.5. By Specialties
      • 5.2.7.2.6. By End User

6. Europe E-Prescribing Solutions Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Delivery Mode
    • 6.2.3. By Usage Method
    • 6.2.4. By Substances
    • 6.2.5. By Specialties
    • 6.2.6. By End User
    • 6.2.7. By Country
      • 6.2.7.1. Germany
      • 6.2.7.1.1. By Product
      • 6.2.7.1.2. By Delivery Mode
      • 6.2.7.1.3. By Usage Method
      • 6.2.7.1.4. By Substances
      • 6.2.7.1.5. By Specialties
      • 6.2.7.1.6. By End User
      • 6.2.7.2. United Kingdom
      • 6.2.7.2.1. By Product
      • 6.2.7.2.2. By Delivery Mode
      • 6.2.7.2.3. By Usage Method
      • 6.2.7.2.4. By Substances
      • 6.2.7.2.5. By Specialties
      • 6.2.7.2.6. By End User
      • 6.2.7.3. Italy
      • 6.2.7.3.1. By Product
      • 6.2.7.3.2. By Delivery Mode
      • 6.2.7.3.3. By Usage Method
      • 6.2.7.3.4. By Substances
      • 6.2.7.3.5. By Specialties
      • 6.2.7.3.6. By End User
      • 6.2.7.4. France
      • 6.2.7.4.1. By Product
      • 6.2.7.4.2. By Delivery Mode
      • 6.2.7.4.3. By Usage Method
      • 6.2.7.4.4. By Substances
      • 6.2.7.4.5. By Specialties
      • 6.2.7.4.6. By End User
      • 6.2.7.5. Spain
      • 6.2.7.5.1. By Product
      • 6.2.7.5.2. By Delivery Mode
      • 6.2.7.5.3. By Usage Method
      • 6.2.7.5.4. By Substances
      • 6.2.7.5.5. By Specialties
      • 6.2.7.5.6. By End User
      • 6.2.7.6. Belgium
      • 6.2.7.6.1. By Product
      • 6.2.7.6.2. By Delivery Mode
      • 6.2.7.6.3. By Usage Method
      • 6.2.7.6.4. By Substances
      • 6.2.7.6.5. By Specialties
      • 6.2.7.6.6. By End User
      • 6.2.7.7. Russia
      • 6.2.7.7.1. By Product
      • 6.2.7.7.2. By Delivery Mode
      • 6.2.7.7.3. By Usage Method
      • 6.2.7.7.4. By Substances
      • 6.2.7.7.5. By Specialties
      • 6.2.7.7.6. By End User
      • 6.2.7.8. The Netherlands
      • 6.2.7.8.1. By Product
      • 6.2.7.8.2. By Delivery Mode
      • 6.2.7.8.3. By Usage Method
      • 6.2.7.8.4. By Substances
      • 6.2.7.8.5. By Specialties
      • 6.2.7.8.6. By End User
      • 6.2.7.9. Rest of Europe
      • 6.2.7.9.1. By Product
      • 6.2.7.9.2. By Delivery Mode
      • 6.2.7.9.3. By Usage Method
      • 6.2.7.9.4. By Substances
      • 6.2.7.9.5. By Specialties
      • 6.2.7.9.6. By End User

7. Asia-Pacific E-Prescribing Solutions Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Delivery Mode
    • 7.2.3. By Usage Method
    • 7.2.4. By Substances
    • 7.2.5. By Specialties
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Product
      • 7.2.6.1.2. By Delivery Mode
      • 7.2.6.1.3. By Usage Method
      • 7.2.6.1.4. By Substances
      • 7.2.6.1.5. By Specialties
      • 7.2.6.1.6. By End User
      • 7.2.6.2. India
      • 7.2.6.2.1. By Product
      • 7.2.6.2.2. By Delivery Mode
      • 7.2.6.2.3. By Usage Method
      • 7.2.6.2.4. By Substances
      • 7.2.6.2.5. By Specialties
      • 7.2.6.2.6. By End User
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Product
      • 7.2.6.3.2. By Delivery Mode
      • 7.2.6.3.3. By Usage Method
      • 7.2.6.3.4. By Substances
      • 7.2.6.3.5. By Specialties
      • 7.2.6.3.6. By End User
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Product
      • 7.2.6.4.2. By Delivery Mode
      • 7.2.6.4.3. By Usage Method
      • 7.2.6.4.4. By Substances
      • 7.2.6.4.5. By Specialties
      • 7.2.6.4.6. By End User
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Product
      • 7.2.6.5.2. By Delivery Mode
      • 7.2.6.5.3. By Usage Method
      • 7.2.6.5.4. By Substances
      • 7.2.6.5.5. By Specialties
      • 7.2.6.5.6. By End User
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Product
      • 7.2.6.6.2. By Delivery Mode
      • 7.2.6.6.3. By Usage Method
      • 7.2.6.6.4. By Substances
      • 7.2.6.6.5. By Specialties
      • 7.2.6.6.6. By End User
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Product
      • 7.2.6.7.2. By Delivery Mode
      • 7.2.6.7.3. By Usage Method
      • 7.2.6.7.4. By Substances
      • 7.2.6.7.5. By Specialties
      • 7.2.6.7.6. By End User
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Product
      • 7.2.6.8.2. By Delivery Mode
      • 7.2.6.8.3. By Usage Method
      • 7.2.6.8.4. By Substances
      • 7.2.6.8.5. By Specialties
      • 7.2.6.8.6. By End User
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Product
      • 7.2.6.9.2. By Delivery Mode
      • 7.2.6.9.3. By Usage Method
      • 7.2.6.9.4. By Substances
      • 7.2.6.9.5. By Specialties
      • 7.2.6.9.6. By End User
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Product
      • 7.2.6.10.2. By Delivery Mode
      • 7.2.6.10.3. By Usage Method
      • 7.2.6.10.4. By Substances
      • 7.2.6.10.5. By Specialties
      • 7.2.6.10.6. By End User

8. Latin America E-Prescribing Solutions Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Delivery Mode
    • 8.2.3. By Usage Method
    • 8.2.4. By Substances
    • 8.2.5. By Specialties
    • 8.2.6. By End User
    • 8.2.7. By Country
      • 8.2.7.1. Brazil
      • 8.2.7.1.1. By Product
      • 8.2.7.1.2. By Delivery Mode
      • 8.2.7.1.3. By Usage Method
      • 8.2.7.1.4. By Substances
      • 8.2.7.1.5. By Specialties
      • 8.2.7.1.6. By End User
      • 8.2.7.2. Mexico
      • 8.2.7.2.1. By Product
      • 8.2.7.2.2. By Delivery Mode
      • 8.2.7.2.3. By Usage Method
      • 8.2.7.2.4. By Substances
      • 8.2.7.2.5. By Specialties
      • 8.2.7.2.6. By End User
      • 8.2.7.3. Argentina
      • 8.2.7.3.1. By Product
      • 8.2.7.3.2. By Delivery Mode
      • 8.2.7.3.3. By Usage Method
      • 8.2.7.3.4. By Substances
      • 8.2.7.3.5. By Specialties
      • 8.2.7.3.6. By End User
      • 8.2.7.4. Peru
      • 8.2.7.4.1. By Product
      • 8.2.7.4.2. By Delivery Mode
      • 8.2.7.4.3. By Usage Method
      • 8.2.7.4.4. By Substances
      • 8.2.7.4.5. By Specialties
      • 8.2.7.4.6. By End User
      • 8.2.7.5. Rest of LATAM
      • 8.2.7.5.1. By Product
      • 8.2.7.5.2. By Delivery Mode
      • 8.2.7.5.3. By Usage Method
      • 8.2.7.5.4. By Substances
      • 8.2.7.5.5. By Specialties
      • 8.2.7.5.6. By End User

9. Middle East & Africa E-Prescribing Solutions Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Delivery Mode
    • 9.2.3. By Usage Method
    • 9.2.4. By Substances
    • 9.2.5. By Specialties
    • 9.2.6. By End User
    • 9.2.7. By Country
      • 9.2.7.1. Saudi Arabia
      • 9.2.7.1.1. By Product
      • 9.2.7.1.2. By Delivery Mode
      • 9.2.7.1.3. By Usage Method
      • 9.2.7.1.4. By Substances
      • 9.2.7.1.5. By Specialties
      • 9.2.7.1.6. By End User
      • 9.2.7.2. UAE
      • 9.2.7.2.1. By Product
      • 9.2.7.2.2. By Delivery Mode
      • 9.2.7.2.3. By Usage Method
      • 9.2.7.2.4. By Substances
      • 9.2.7.2.5. By Specialties
      • 9.2.7.2.6. By End User
      • 9.2.7.3. Qatar
      • 9.2.7.3.1. By Product
      • 9.2.7.3.2. By Delivery Mode
      • 9.2.7.3.3. By Usage Method
      • 9.2.7.3.4. By Substances
      • 9.2.7.3.5. By Specialties
      • 9.2.7.3.6. By End User
      • 9.2.7.4. Kuwait
      • 9.2.7.4.1. By Product
      • 9.2.7.4.2. By Delivery Mode
      • 9.2.7.4.3. By Usage Method
      • 9.2.7.4.4. By Substances
      • 9.2.7.4.5. By Specialties
      • 9.2.7.4.6. By End User
      • 9.2.7.5. South Africa
      • 9.2.7.5.1. By Product
      • 9.2.7.5.2. By Delivery Mode
      • 9.2.7.5.3. By Usage Method
      • 9.2.7.5.4. By Substances
      • 9.2.7.5.5. By Specialties
      • 9.2.7.5.6. By End User
      • 9.2.7.6. Nigeria
      • 9.2.7.6.1. By Product
      • 9.2.7.6.2. By Delivery Mode
      • 9.2.7.6.3. By Usage Method
      • 9.2.7.6.4. By Substances
      • 9.2.7.6.5. By Specialties
      • 9.2.7.6.6. By End User
      • 9.2.7.7. Algeria
      • 9.2.7.7.1. By Product
      • 9.2.7.7.2. By Delivery Mode
      • 9.2.7.7.3. By Usage Method
      • 9.2.7.7.4. By Substances
      • 9.2.7.7.5. By Specialties
      • 9.2.7.7.6. By End User
      • 9.2.7.8. Rest of MEA
      • 9.2.7.8.1. By Product
      • 9.2.7.8.2. By Delivery Mode
      • 9.2.7.8.3. By Usage Method
      • 9.2.7.8.4. By Substances
      • 9.2.7.8.5. By Specialties
      • 9.2.7.8.6. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global E-Prescribing Solutions Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global E-Prescribing Solutions Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Medical information technology, Inc.
  • 12.2. Eclinicalworks
  • 12.3. Athenahealth
  • 12.4. Epic Systems Corporation
  • 12.5. Change healthcare
  • 12.6. Surescripts
  • 12.7. Practice Fusion
  • 12.8. Drfirst
  • 12.9. Allscripts Healthcare Solutions, Inc.
  • 12.10. Cerner Corporation
  • 12.11. NextGen Healthcare, Inc.
  • 12.12. eMDs, Inc.
  • 12.13. Greenway Health, LLC
  • 12.14. Stratice Healthcare
  • 12.15. Computer Programs and Systems Inc.
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations